PMID- 18513453 OWN - NLM STAT- MEDLINE DCOM- 20080723 LR - 20211203 IS - 1471-2431 (Electronic) IS - 1471-2431 (Linking) VI - 8 DP - 2008 Jun 2 TI - Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial. PG - 23 LID - 10.1186/1471-2431-8-23 [doi] AB - BACKGROUND: For children at high risk of chronic suppurative otitis media (CSOM), strategies to prevent acute otitis media with perforation (AOMwiP) may reduce progression to CSOM. METHODS: In a double blind study in northern Australia, 103 Aboriginal infants with first detection of OME were randomised to receive either amoxicillin (50 mg/kg/d BD) or placebo for 24 weeks, or until bilateral aerated middle ears were diagnosed at two successive monthly examinations (success). Standardised clinical assessments and international standards for microbiology were used. RESULTS: Five of 52 infants in the amoxicillin group and none of 51 infants in the placebo group achieved success at the end of therapy (Risk Difference = 9.6% [95% confidence interval 1.6,17.6]). Amoxicillin significantly reduced the proportion of children with i) perforation at the end of therapy (27% to 12% RD = -16% [-31,-1]), ii) recurrent perforation during therapy (18% to 4% RD = -14% [-25,-2]), and iii) reduced the proportion of examinations with a diagnosis of perforation during therapy (20% to 8% adjusted risk ratio 0.36 [0.15,0.83] p = 0.017). During therapy, the proportion of examinations with penicillin non-susceptible (MIC > 0.1 microg/ml) pneumococci was not significantly different between the amoxicillin group (34%) and the placebo group (40%). Beta-lactamase positive non-capsular H. influenzae (NCHi) were uncommon during therapy but more frequent in the amoxicillin group (10%) than placebo (5%). CONCLUSION: Aboriginal infants receiving continuous amoxicillin had more normal ears, fewer perforations, and less pneumococcal carriage. There was no statistically significant increase in resistant pneumococci or NCHi in amoxicillin children compared to placebo children who received regular paediatric care and antibiotic treatment for symptomatic illnesses. FAU - Leach, Amanda J AU - Leach AJ AD - Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia. amanda@menzies.edu.au FAU - Morris, Peter S AU - Morris PS FAU - Mathews, John D AU - Mathews JD CN - Chronic Otitis Media Intervention Trial - One (COMIT1) group LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20080602 PL - England TA - BMC Pediatr JT - BMC pediatrics JID - 100967804 RN - 0 (Anti-Bacterial Agents) RN - 804826J2HU (Amoxicillin) SB - IM MH - Amoxicillin/*administration & dosage MH - Anti-Bacterial Agents/*administration & dosage MH - Australia MH - Bacteria/isolation & purification MH - Confidence Intervals MH - Double-Blind Method MH - Drug Administration Schedule MH - Humans MH - Infant MH - Infant, Newborn MH - Microbial Sensitivity Tests MH - Nasopharynx/microbiology MH - Native Hawaiian or Other Pacific Islander MH - Otitis Media with Effusion/complications/*drug therapy/ethnology/microbiology MH - Risk Assessment MH - Tympanic Membrane Perforation/etiology/*prevention & control PMC - PMC2443129 FIR - Hayhurst, Bev IR - Hayhurst B FIR - Koops, Harold IR - Koops H FIR - Melder, Angela IR - Melder A FIR - Pulakui, Monica IR - Pulakui M FIR - Stubbs, Liz IR - Stubbs L FIR - Hare, Kim IR - Hare K FIR - Beissbarth, Jemima IR - Beissbarth J FIR - Smith-Vaughan, Heidi IR - Smith-Vaughan H FIR - Stubbs, Liz IR - Stubbs L FIR - Leach, Seija IR - Leach S FIR - Liddle, Robyn IR - Liddle R FIR - Donath, Susan IR - Donath S FIR - Jacklyn, Susan IR - Jacklyn S FIR - McDonnell, Joseph IR - McDonnell J FIR - Bex, Jo IR - Bex J FIR - Hutton, Sue IR - Hutton S FIR - Lukitch, Abe IR - Lukitch A EDAT- 2008/06/03 09:00 MHDA- 2008/07/24 09:00 PMCR- 2008/06/02 CRDT- 2008/06/03 09:00 PHST- 2007/12/14 00:00 [received] PHST- 2008/06/02 00:00 [accepted] PHST- 2008/06/03 09:00 [pubmed] PHST- 2008/07/24 09:00 [medline] PHST- 2008/06/03 09:00 [entrez] PHST- 2008/06/02 00:00 [pmc-release] AID - 1471-2431-8-23 [pii] AID - 10.1186/1471-2431-8-23 [doi] PST - epublish SO - BMC Pediatr. 2008 Jun 2;8:23. doi: 10.1186/1471-2431-8-23.